A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.

Br J Cancer · 2015 · PMC4506385 · PMID 26151457

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

A significant trend for increased CFB expression was found in the six patients who had clinical benefit with improved PFS but not OS ( Supplementary Table 2 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.